- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x E9P: 5-ETHYL-2-PHENOXYPHENOL
E9P.2: 13 residues within 4Å:- Chain A: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230
- Ligands: NAP.1
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:A.121, A:L.128, A:Y.173, A:Y.173, A:Y.173, A:Y.183, A:A.224, A:V.227, A:F.230
E9P.5: 12 residues within 4Å:- Chain B: A.121, F.122, A.123, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230
- Ligands: NAP.4
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:A.121, B:Y.173, B:Y.173, B:Y.173, B:Y.183, B:A.224, B:V.227, B:F.230
E9P.9: 14 residues within 4Å:- Chain C: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230, I.233
- Ligands: NAP.8
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:A.121, C:L.128, C:Y.173, C:Y.173, C:Y.173, C:Y.183, C:A.224, C:V.227, C:F.230, C:I.233
- Hydrogen bonds: C:Y.183
E9P.12: 12 residues within 4Å:- Chain D: A.121, F.122, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, I.233
- Ligands: NAP.11
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:A.121, D:L.128, D:Y.173, D:Y.173, D:Y.173, D:Y.183, D:A.224, D:V.227, D:I.233
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
GLU.3: 4 residues within 4Å:- Chain A: R.129, G.229, F.230, N.231
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Ligand interactions- Hydrogen bonds: A:G.229, A:N.231, E.3, E.3
- Salt bridges: A:R.129
GLU.6: 4 residues within 4Å:- Chain B: R.129, G.228, G.229, N.231
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Ligand interactions- Hydrogen bonds: B:G.229, B:N.231, E.6, E.6
- Salt bridges: B:R.129
GLU.7: 9 residues within 4Å:- Chain B: K.33, D.114, G.166, S.167, N.208, R.210, L.260, S.261, S.265
6 PLIP interactions:4 interactions with chain B, 2 Ligand-Ligand interactions- Hydrogen bonds: B:G.166, B:L.260, E.7, E.7
- Salt bridges: B:K.33, B:R.210
GLU.10: 5 residues within 4Å:- Chain C: R.129, G.228, G.229, F.230, N.231
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Ligand interactions- Hydrogen bonds: C:G.229, C:N.231, E.10, E.10
- Salt bridges: C:R.129
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Staphylococcus Aureus Fabi: Inhibition, Substrate Recognition and Potential Implications for in Vivo Essentiality. Structure (2012)
- Release Date
- 2012-05-09
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x E9P: 5-ETHYL-2-PHENOXYPHENOL
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Staphylococcus Aureus Fabi: Inhibition, Substrate Recognition and Potential Implications for in Vivo Essentiality. Structure (2012)
- Release Date
- 2012-05-09
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H